When was the company founded?

    The Company was founded in 2011 in Delaware based on technology developed in Israel.

    How many employees does DarioHealth have?

    The company currently has 60 full-time employees.

    How can I obtain copies of DarioHealth financial reports, or request an investor kit or annual report?

    Financial reports are available in the “SEC Filings” page of the “Investors” section of the company’s website. An electronic investor kit is available in the “Electronic IR Kit” section.

    Where can I find DarioHealth’s latest investor presentation?

    DarioHealth’s most recent investor presentation is available on the “Investors” section on the company’s website.


    Financial Reporting & Stock Information:

    When is DarioHealth’s fiscal year end?

    The fiscal year ends on December 31.

    Where is DarioHealth’s stock traded?

    The stock is traded on the NASDAQ under the symbol DRIO.

    Does DarioHealth pay dividends on its common stock?

    DarioHealth has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.


    External Advisors and Contact Information:

    Who are DarioHealth’s independent auditors?

    A Member of Ernst & Young Global
    Aminadav St. 3, Tel Aviv, Israel, 6706703, Israel

    Who do I contact to request information on my account or change my account information?

    Questions regarding stock holdings, certificate replacement/transfer and address changes should be directed to our Transfer Agent:

    VStock Transfer, LLC
    77 Spruce Street, Suite 201
    Cedarhurst, NY 11516
    Attention: Yoel Goldfeder
    Phone:  212-828-8436
    Toll-Free: 855-9VSTOCK
    Fax: 646-536-3179

    Who is DarioHealth’s outside corporate counsel?

    Sullivan & Worcester LLP
    1633 Broadway
    New York, NY 10019
    Phone:  212-660-5002
    Fax: 212-660-3001

    How do I contact DarioHealth’s Investor Relations?

    Please call +1-347-767-4220 or send an email to IR@mydario.com.